Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

The FDA approved Yeztugo (lenacapavir), a twice-yearly injection that prevents HIV with up to 99.9% effectiveness, showing ...

The Southern Eye The information was released during a recent National Aids Council (Nac) media sensitisation workshop held ...

Greek City Times Scientists Delete HIV from Human Cells in World-First Breakthrough Scientists have successfully deleted the ...

Newsday Zimbabwe Health and Child Care minister Douglas Mombeshora, however, was quick to allay the fears saying the increase ...

The FDA has approved Yeztugo, the first long-acting injectable PrEP shot, which could significantly impact HIV prevention ...

Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

Residents can avail of a fresh opportunity for conversations on HIV this month, the Ministry of Health announced. An HIV ...